Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 4 of 4 for “"ZCZ011"”.
-
Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain
… have shown antinociceptive efficacy in CCI with ZCZ011 and its analogs, GAT211 and ABD1236, producing dose and time-dependent reversal of allodynia (Ignatowska-Jankowska et al. 2015; Slivicki et al. 2018; Tseng et al. 2019). This study reports the activity of the 2-phenyl indole class of CB1 PAMs …
-
Acute and Repeated Effects of Synthetic Cannabinoid Agonism and Cannabinoid Receptor 1 Positive Allosteric Modulation
… a need for pharmacological interventions. ZCZ011 is a CB1 positive allosteric modulator that increases the effect of CB1 agonists bound at the orthosteric site. We hypothesized that ZCZ011 significantly attenuates behavioral signs of cannabinoid withdrawal. Mice were administered ∆9-THC (10 …
-
The CB1 Receptor Positive Allosteric Modulator, ZCZ011, Attenuates Naloxone-Precipitated Withdrawal Signs in Oxycodone-Dependent Mice and Inhibits Small Intestinal Transit in Mice
… Furthermore, the CB1 receptor PAM, ZCZ011, does not substitute for the synthetic cannabinoid, CP55,940, in C57BL/6J mice or AEA in FAAH (-/-) mice in the drug discrimination paradigm. Therefore, the objectives of this dissertation are to (1) assess the efficacy of the CB1 receptor …
-
CB1 Allosteric Modulation: Preclinical Insights into Therapeutic Potential and Misuse Liability
… chiral CB1 positive allosteric modulator (PAM) ZCZ011 was resolved into its R- and S-enantiomers and characterized across in vitro and in vivo assays. Both enantiomers enhance CB1 agonist activity and produce intrinsic effects in vitro. Behaviorally, they produce antinociceptive effects in the …